Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 1;208(3):222-224.
doi: 10.1164/rccm.202306-0969ED.

Enhancing the Efficacy of Mesenchymal Stromal Cells in COVID-19-related Acute Respiratory Distress Syndrome

Haibo Zhang  1   2   3   4 , Arthur S Slutsky  1   4
Affiliations
Editorial

Enhancing the Efficacy of Mesenchymal Stromal Cells in COVID-19-related Acute Respiratory Distress Syndrome

Haibo Zhang et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Suggested future lines of research for MSCs in patients with acute respiratory distress syndrome. MSCs = mesenchymal stromal cells.
See this image and copyright information in PMC

Comment on

References

    1. Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med . 2012;18:759–765. - PMC - PubMed
    1. Matthay MA, Calfee CS, Zhuo H, Thompson BT, Wilson JG, Levitt JE, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med . 2019;7:154–162. - PMC - PubMed
    1. Gorman EA, Rynne J, Gardiner HJ, Rostron AJ, Bannard-Smith J, Bentley AM, et al. Repair of acute respiratory distress syndrome in COVID-19 by stromal cells (REALIST-COVID trial): a multicentre, randomised, controlled trial. Am J Respir Crit Care Med . 2023;208:256–269. - PubMed
    1. Adamos G, Gavrielatou E, Sarri K, Kokkoris S. Heterogeneity of acute respiratory distress syndrome. Am J Respir Crit Care Med . 2020;201:728–730. - PubMed
    1. Juschten J, Tuinman PR, Guo T, Juffermans NP, Schultz MJ, Loer SA, et al. Between-trial heterogeneity in ARDS research. Intensive Care Med . 2021;47:422–434. - PMC - PubMed